A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine.

Nonviral gene transfer into the central nervous system (CNS) offers the prospect of providing safe therapies for neurological disorders and manipulating gene expression for studying neuronal function. However, results reported so far have been disappointing. We show that the cationic polymer polyethylenimine (PEI) provides unprecedentedly high levels of transgene expression in the mature mouse brain. Three different preparations of PEI (25-, 50-, and 800-kD) were compared for their transfection efficiencies in the brains of adult mice. The highest levels of transfection were obtained with the 25-kD polymer. With this preparation, DNA/PEI complexes bearing mean ionic charge ratios closest to neutrality gave the best results. Under such conditions, and using a cytomegalovirus (CMV)-luciferase construction, we obtained up to 0.4 10(6) RLU/microgram DNA (equivalent to 0.4 ng of luciferase), which is close to the values obtained using PEI to transfect neuronal cultures and the more easily transfected newborn mouse brain (10(6) RLU/microgram DNA). Widespread expression (over 6 mm3) of marker (luciferase) or functional genes (bcl2) was obtained in neurons and glia after injection into the cerebral cortex, hippocampus, and hypothalamus. Transgene expression was found more than 3 months post-injection in cortical neurons. No morbidity was observed with any of the preparations used. Thus, PEI, a low-toxicity vector, appears to have potential for fundamental research and genetic therapy of the brain.

[1]  D. Scherman,et al.  Gene transfer by naked DNA into adult mouse brain. , 1996, Gene therapy.

[2]  F. Gage,et al.  In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.

[3]  D. Scherman,et al.  Lipospermine-based gene transfer into the newborn mouse brain is optimized by a low lipospermine/DNA charge ratio. , 1995, Human gene therapy.

[4]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[5]  E. Snyder,et al.  Neural progenitor cell engraftment corrects lysosomal storage throughout the MRS VII mouse brain , 1995, Nature.

[6]  L. Soroceanu,et al.  Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[7]  D. Pfaff,et al.  Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors. , 1994, Gene therapy.

[8]  O. Isacson,et al.  Effect of exogenous nerve growth factor on neurotoxicity of and neuronal gene delivery by a herpes simplex amplicon vector in the rat brain. , 1994, Human gene therapy.

[9]  M. Cotten,et al.  Lipopolysaccharide is a frequent contaminant of plasmid DNA preparations and can be toxic to primary human cells in the presence of adenovirus. , 1994, Gene therapy.

[10]  F. Gage,et al.  Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[11]  T. Tamiya,et al.  Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors. , 1994, Human gene therapy.

[12]  Donald W. Pfaff,et al.  Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain , 1994, Nature Genetics.

[13]  A. Rundell,et al.  Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. , 1993, Human gene therapy.

[14]  B. Demeneix,et al.  Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. , 1993, Human gene therapy.

[15]  Sanford H. Feldman,et al.  Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors , 1993, Nature Genetics.

[16]  Blake J. Roessler,et al.  A model system for in vivo gene transfer into the central nervous system using an adenoviral vector , 1993, Nature Genetics.

[17]  M. Perricaudet,et al.  An adenovirus vector for gene transfer into neurons and glia in the brain , 1993, Science.

[18]  M. Perricaudet,et al.  Transfer of a foreign gene into the brain using adenovirus vectors , 1993, Nature Genetics.

[19]  Fenguangzhai Song.  CD , 1992 .

[20]  J. Martinou,et al.  Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. , 1992, Science.

[21]  Z. Ram,et al.  In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. , 1992, Science.

[22]  Z. Mi,et al.  Serotonergic, noradrenergic and galaninergic projections to the nucleus parafascicularis , 1992, Neuroreport.

[23]  M. Tsuda,et al.  Plasmid DNAs directly injected into mouse brain with lipofectin can be incorporated and expressed by brain cells , 1990, Neuroscience Letters.

[24]  R. McKay.  The origins of cellular diversity in the mammalian central nervous system , 1989, Cell.

[25]  J. Behr,et al.  Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Northrop,et al.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .